Literature DB >> 8358345

Evaluation of the monoamine uptake site ligand [123I]methyl 3 beta-(4-iodophenyl)-tropane-2 beta-carboxylate ([123I]beta-CIT) in non-human primates: pharmacokinetics, biodistribution and SPECT brain imaging coregistered with MRI.

R M Baldwin1, Y Zea-Ponce, S S Zoghbi, M Laurelle, M S al-Tikriti, E H Sybirska, R T Malison, J L Neumeyer, R A Milius, S Wang.   

Abstract

The in vivo properties of a new radioiodinated probe of the dopamine and serotonin transporter, [123I]methyl 3 beta-(4-iodophenyl)tropane-2 beta-carboxylate ([123I]beta-CIT) were evaluated in baboons and vervet monkeys. The labeled product was prepared in 65.2 +/- 2.8% yield (mean +/- SEM; n = 18) by reaction of the tributylstannyl precursor with [123I]NaI in the presence of peracetic acid followed by high pressure liquid chromatography (HPLC) purification to give a product with radiochemical purity of 97.5 +/- 0.5% and specific activity of 500-1200 Ci/mmol. After intravenous administration, whole brain activity peaked at 6-10% injected dose within 1 h post injection (p.i.) and washed out in a biphasic manner with clearance half-lives of 1-2 and 7-35 h for the rapid and slow components, respectively. Excretion occurred primarily through the hepatobiliary route, with about 30% of the injected dose appearing in the GI tract after 5 h. Estimates of radiation absorbed dose gave 0.01, 0.1, 0.2 and 0.03 mGy/MBq to the brain, gall bladder wall, lower large intestine wall and urinary bladder wall, respectively. High resolution SPECT imaging in a baboon demonstrated high uptake of tracer in the region of the striatum (striatum:cerebellum ratio 4.0), in the hypothalamus (ratio 2.6) and in a midbrain region comprising raphe, substantia nigra and superior colliculus (ratio 2.0), with regional brain uptakes measured at 210 min p.i. of [123I]beta-CIT. The anatomical locations of the regions on the SPECT image were confirmed by coregistration with MRI. Plasma metabolites and pharmacokinetics were analyzed in baboons and vervets by ethyl acetate extraction and HPLC. The major metabolite was a polar, non-extractable fraction, which increased to > 50% of the plasma activity by 30-45 min p.i. A minor lipophilic (extractable) metabolite was also observed, increasing to about 4% at 2-3 h p.i. The plasma protein bound fraction, determined by ultrafiltration, was 74.8 +/- 1.4% (n = 6). The arterial input function was characterized by the sum of three exponential terms with half-lives of 0.3-1.7, 9.7-24.9 and 77-166 min, respectively, for the concentration of free parent compound. [123I]beta-CIT promises to be a useful marker for SPECT study of the monoamine uptake system in primate brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358345     DOI: 10.1016/0969-8051(93)90028-s

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  12 in total

1.  Dopamine and serotonin transporter availability in chronic heroin users: a [¹²³I]β-CIT SPECT imaging study.

Authors:  Kelly P Cosgrove; Karen Tellez-Jacques; Brian Pittman; Ismene Petrakis; Ronald M Baldwin; Gilles Tamagnan; John Seibyl; Thomas Kosten; Julie K Staley
Journal:  Psychiatry Res       Date:  2010-11-03       Impact factor: 3.222

2.  Synthesis and radioiodination of a stannyl oligodeoxyribonucleotide.

Authors:  H Dougan; J B Hobbs; J I Weitz; D M Lyster
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

3.  Effects of cocaine on [11C]norepinephrine and [11C] beta-CIT uptake in the primate peripheral organs measured by PET.

Authors:  T Suhara; L Farde; C Halldin; K Någren; P Karlsson
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

4.  Synthesis, radiolabeling and baboon SPECT imaging of 2beta-carbomethoxy-3beta-(3'-[(123)I]iodophenyl)tropane ([(123)I]YP256) as a serotonin transporter radiotracer.

Authors:  Frederic Bois; Ronald M Baldwin; Louis Amici; Mohammed S Al-Tikriti; Nora Kula; Ross Baldessarini; Robert B Innis; Julie K Staley; Gilles D Tamagnan
Journal:  Nucl Med Biol       Date:  2008-01       Impact factor: 2.408

5.  Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder.

Authors:  Franklin R Schneier; Anissa Abi-Dargham; Diana Martinez; Mark Slifstein; Dah-Ren Hwang; Michael R Liebowitz; Marc Laruelle
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

6.  Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates.

Authors:  B E Scanley; M S al-Tikriti; M S Gandelman; M Laruelle; Y Zea-Ponce; R M Baldwin; S S Zoghbi; P B Hoffer; D S Charney; S Wang
Journal:  Eur J Nucl Med       Date:  1995-01

7.  Initial experience with single-photon emission tomography using iodine-123-labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl) tropane in human brain.

Authors:  J T Kuikka; K A Bergström; E Vanninen; V Laulumaa; P Hartikainen; E Länsimies
Journal:  Eur J Nucl Med       Date:  1993-09

8.  Radiolabeled 5-iodo-3'-O-(17beta-succinyl-5alpha-androstan-3-one)-2'-deoxyuridine and its 5'-monophosphate for imaging and therapy of androgen receptor-positive cancers: synthesis and biological evaluation.

Authors:  Zbigniew P Kortylewicz; Jessica Nearman; Janina Baranowska-Kortylewicz
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

9.  Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.

Authors:  R B Innis; J P Seibyl; B E Scanley; M Laruelle; A Abi-Dargham; E Wallace; R M Baldwin; Y Zea-Ponce; S Zoghbi; S Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

10.  Bayesian convolutional neural network based MRI brain extraction on nonhuman primates.

Authors:  Gengyan Zhao; Fang Liu; Jonathan A Oler; Mary E Meyerand; Ned H Kalin; Rasmus M Birn
Journal:  Neuroimage       Date:  2018-03-28       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.